Bronchial anthracofibrosis: The spectrum of radiological appearances

Abstract

Bronchial anthracofibrosis (BAF), caused by long-standing exposure to biomass fuel smoke, has emerged as a distinct pulmonary disease. It is usually seen in elderly females who have worked long hours in poorly ventilated kitchen full of smoke due to incomplete combustion of biomass fuel. The diagnosis is confirmed on bronchoscopic visualization of bluish-black anthracotic pigmentation along with narrowing/distortion of the affected bronchus. BAF has been associated with clinical conditions such as pulmonary tuberculosis, chronic obstructive pulmonary disease, pneumonia, and malignancy. Tuberculosis, once thought to be the causative agent for BAF, is now considered to be an association. BAF has a diverse radiological presentation and the presence of associated clinical conditions often confound the radiological picture. The imaging features of BAF include primary imaging characteristics, which pertains to the disease entity directly, and secondary features based on the presence of associated conditions. High-resolution computed tomography findings of multifocal bronchial narrowing and peribronchial cuffing are considered to be specific diagnostic features of BAF. In addition, the diagnostic probability is increased in the presence of mediastinal adenopathy and collapse/atelectasis with middle lobe syndrome being the most common presentation. This pictorial essay highlights the range of imaging appearances in patients with BAF.

Keywords

Anthracosis - biomass fuel smoke exposure - bronchial anthracofibrosis - fiberoptic bronchoscopy - high-resolution computed tomography - imaging

Publication History

Article published online:
26 July 2021

• References

• 1 Gupta A, Shah A. Bronchial anthracofibrosis: An emerging pulmonary disease due to biomass fuel exposure. Int J Tuberc Lung Dis 2011; 15: 602-12
• 2 World Health Organization. Geneva, Switzerland: World Health Organization; 2010. World Health Statistics, 2010. Available from URL: http://www.who.int/whosis/whostat/2010/en/(accessed on July 17, 2017)
• 3 World Health Organization. The World health statistics: 2012. Available from URL: http://www.who.int/whois/whostat/2012/ en/(accessed on July 17, 2017)
• 4 Shah A. Bronchial anthracofibrosis: A perilous consequence of exposure to biomass fuel smoke [Editorial]. Indian J Chest Dis Allied Sci 2015; 57: 151-3
• 5 Chung MP, Lee KS, Han J, Kim H, Rhee CH, Han YC. et al. Bronchial stenosis due to anthracofibrosis. Chest 1998; 113: 344-5
• 6 Klotz O. Pulmonary anthracosis -a community disease. Am J Public Health (NY) 1914; 4: 887-916
• 7 Cohen AG. Atelectasis of the right middle lobe resulting from perforation of tuberculous lymph nodes into bronchi in adults. Ann Intern Med 1951; 35: 820-35
• 8 Sigari N, Mohammadi S. Anthracosis and anthracofibrosis. Saudi Med J 2009; 30: 1063-6
• 9 Kim YJ, Jung CY, Shin HW, Lee BK. Biomass smoke induced bronchial anthracofibrosis: Presenting features and clinical course. Respir Med 2009; 103: 757-65
• 10 Pilaniya V, Kunal S, Shah A. Occurrence of bronchial anthracofibrosis in respiratory symptomatics with exposure to biomass fuel smoke. Adv Respir Med 2017; 85: 127-35
• 11 Kala J, Sahay S, Shah A. Bronchial anthracofibrosis and tuberculosis presenting as a middle lobe syndrome. Prim Care Respir J 2008; 17: 51-5
• 12 Kim HY, Im JG, Goo JM. Bronchial anthracofibrosis (inflammatory bronchial stenosis with anthracotic pigmentation): CT findings. AJR Am J Roentgenol 2000; 174: 523-7
• 13 Kahkouee S, Pourghorban R, Bitarafan M, Najafizadeh K, Makki SS. Imaging findings of isolated bronchial anthracofibrosis: A computed tomography analysis of patients with bronchoscopic and histologic confirmation. Arch Bronconeumol 2015; 51: 322-7
• 14 Kim HJ, Kim SD, Shin DW, Bae SH, Kim AL, Kim JN. et al. Relationship between bronchial anthracofibrosis and endobronchial tuberculosis. Korean J Intern Med 2013; 28: 330-8
• 15 Criado E, Sánchez M, Ramírez J, Arguis P, de Caralt TM, Perea RJ. et al. Pulmonary sarcoidosis: Typical and atypical manifestations at high-resolution CT with pathologic correlation. Radiographics 2010; 30: 1567-86
• 16 Moran-Mendoza O, Pérez-Padilla JR, Salazar-Flores M, Vazquez-Alfaro F. Wood smoke-associated lung disease: A clinical, functional, radiological and pathological description. Int J Tuberc Lung Dis 2008; 12: 1092-8
• 17 Gupta P. The Golden S sign. Radiology 2004; 233: 790-1
• 18 Kunal S, Shah A. The concomitant occurrence of pulmonary tuberculosis with bronchial anthracofibrosis. Indian J Tuberc 2017; 64: 5-9
• 19 Gudbjartsson T, Gudmundsson G. Middle lobe syndrome: A review of clinicopathological features, diagnosis and treatment. Respiration 2012; 84: 80-6
• 20 Lee HS, Maeng JH, Park PG, Jang JG, Park W, Ryu DS. et al. [Clinical features of simple bronchial anthracofibrosis which is not associated with tuberculosis]. Tuberc Respir Dis 2002; 53: 510-8
• 21 Torun T, Gungor G, Ozmen I, Maden E, Bolukbasi Y, Tahaoglu K. Bronchial anthracostenosis in patients exposed to biomass smoke. Turkish Respir J 2007; 8: 48-51
• 22 Kunal S, Pilaniya V, Shah A. Bronchial anthracofibrosis with interstitial lung disease: An association yet to be highlighted. BMJ Case Rep 2016 pii:bcr2015213940.
• 23 Kunal S, Pilaniya V, Shah A. The co-occurrence of bronchial anthracofibrosis and interstitial lung disease. Arch Bronconeumol 2017; 53: 218-9
• 24 Hansell DM, Bankier AA, MacMahon H, McLoud TC, Müller NL, Remy J. Fleischner Society: Glossary of terms for thoracic imaging. Radiology 2008; 246: 697-722
• 25 Park TY, Heo EY, Chung HS, Jin KN, Kim DK. Prediction of anthracofibrosis based on clinico-radiographic findings. Yonsei Med J 2017; 58: 355-61
• 26 Dhamija A, Basu A, Sharma V, Bakshi P, Verma K. Mediastinal adenopathy in India: Through the eyes of endobranchial ultrasound. J Assoc Physicians India 2015; 63: 15-8
• 27 Choe HS, Lee IJ, Lee Y. [The CT findings of bronchial anthracofibrosis: Comparison of cases with or without active tuberculosis]. J Korean Radiol Soc 2004; 50: 109-14